NRX Pharmaceuticals (NRXP) Interest & Investment Income (2022 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Interest & Investment Income came in at $5000.0 in Q1 2026, up 25.0% year-on-year from $4000.0 in Q1 2025, and up 25.0% on a QoQ basis from $4000.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Interest & Investment Income (2022 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 5 years of Interest & Investment Income data on file, last reported at $5000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 25.0% year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $13000.0, a 38.1% decrease from a year earlier, with the FY2025 full-year figure at $12000.0, down 72.73% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $5000.0, up from $4000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for NRXP reached as high as $145000.0 in Q2 2023 and fell as low as $2000.0 in Q2 2025.
- Historically, Interest & Investment Income has averaged $40687.5 across 5 years, with a median of $6500.0 in 2024.
- On a YoY basis, Interest & Investment Income climbed as much as 575.0% in 2024 and fell as far as 95.17% in 2024.
- Year by year, Interest & Investment Income stood at $130000.0 in 2022, then sank by 43.08% to $74000.0 in 2023, then tumbled by 94.59% to $4000.0 in 2024, then changed by 0.0% to $4000.0 in 2025, then increased by 25.0% to $5000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $5000.0 in Q1 2026, $4000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 145,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 23,000.00 |